October 4, 2017 – Duke University Medical Center/Minnetronix Neuro Pseudomonas, Acinetobacter and Klebsiella are three multidrug resistant (MDR) gram-negative pathogens…
In Vitro Characterization of the Neurapheresis™ System for the Treatment of Cryptococcal Meningitis
October 4, 2017 – Duke University Medical Center/Minnetronix Neuro Cryptococcal Meningitis is caused by Cryptococcus neoformans and is the most…
Minnetronix Maintains Perfect Record with Seventh FDA Inspection
Minnetronix, maintaining our perfect record, has now undergone seven successful FDA Quality System Inspection Technique (QSIT) inspections with No Action…
Heart to Heart: Andrew Jones Visits Minnetronix
Minnetronix manufactured the advanced, easy-to-use and wear Left Ventricular Assist Device (LVAD) module that powered and controlled Andrew Jones’ implanted…
Facility Expansion and Leadership Appointment Signal Growth for Minnetronix
Fueled by rapid growth, Minnesota-based medical technology company expands facilities
Let’s talk about Media opportunities.
Call 612-578-2834 or email beth@LaBreche.com
We are here to help